会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 15. 发明授权
    • Agents for regulation of colon cancer gene expression
    • 用于调节结肠癌基因表达的药剂
    • US06548539B1
    • 2003-04-15
    • US10090866
    • 2002-03-05
    • Stanislaw PikulDaniel R. SoppetPaul E. Young
    • Stanislaw PikulDaniel R. SoppetPaul E. Young
    • A61K3134
    • C07C323/42C07C323/40C07C323/41C07C323/44C07C2601/04C07C2601/08C07C2601/14C07D307/22
    • Compounds of the general structure according to Formula (I) wherein R1 is selected from alkyl, alkenyl, alkynyl, heteroalkyl, haloalkyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, cycloalkyl, and heterocycloalkyl; R2 is selected from alkyl, alkenyl, alkyny, heteroalkyl, haloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl, and heterocycloalkylalkyl; R3 is selected from aryl, heteroaryl, cycloalkyl, and heterocycloalkyl; W is selected from Ch2, O and S; n is 0 to about 3: X is selected from S or O; Y, if present, is selected from a bond, aryl, NH, NR, O or S, where R3 is selected from hydrogen, alkyl, alkenyl, alkynyl, heteroalkyl, haloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl, and heterocycloalkylalkyl; and Z, if present, can represent a bond or is selected from lower alkyl, O or S are disclosed. Also disclosed are uses of such compounds for treating a variety of disease conditions, including cancer.
    • 其中R 1选自烷基,烯基,炔基,杂烷基,卤代烷基,芳基,芳烷基,杂芳基,杂芳基烷基,环烷基和杂环烷基中的根据式(I)的通式结构的化合物; R 2选自烷基,烯基,炔基,杂烷基,卤代烷基,芳基烷基,杂芳基烷基,环烷基烷基和杂环烷基烷基; R 3选自芳基,杂芳基,环烷基和杂环烷基; W选自Ch2,O和S; n为0至约3:X选自S或O; Y如果存在,选自键,芳基,NH,NR,O或S,其中R 3选自氢,烷基,烯基,炔基,杂烷基,卤代烷基,芳基烷基,杂芳基烷基,环烷基烷基和杂环烷基烷基; 和Z如果存在,可以表示键或选自低级烷基,O或S。 还公开了这些化合物用于治疗各种疾病状况(包括癌症)的用途。
    • 19. 发明授权
    • Peptidoglycan recognition proteins
    • 肽聚糖识别蛋白
    • US07368244B2
    • 2008-05-06
    • US11214796
    • 2005-08-31
    • Paul E. YoungSteven M. RubenCraig A. RosenHenrik S. Olsen
    • Paul E. YoungSteven M. RubenCraig A. RosenHenrik S. Olsen
    • C07H21/00
    • C07K14/47A61K38/00
    • The present invention related to three novel peptidoglican recognition binding protein expressed by keratinocytes, wound-healing tissues and chondrosarcoma tissue. More specifically, isolated nucleic acid molecules are provided encoding human peptidoglycan recognition protein-related proteins, referred to herein as PGRP-K (Keratinocytes), PGRP-W (Wound-healing), and PGRP-C (Chondrosarcoma) of FIGS. 1A-B, FIGS. 2A-C, and FIG. 3, respectively, each having homology to both human peptidoglycan recognition protein (PGRP) as well as murine Tag-7. PGRP-K, PGRP-W, and PGRP-C polypeptides are also provided. Further provided are vectors, host cells and recombinant methods for producing the same. The invention also relates to both the inhibition and enhancement of activities of PGRP-K, PGRP-W, and PGRP-c polypeptides and diagnostic methods for detecting PGRP-K, PGRP-W, and PGRP-C gene expression.
    • 本发明涉及由角质形成细胞,伤口愈合组织和软骨肉瘤组织表达的三种新型肽基识别结合蛋白。 更具体地,提供分离的核酸分子,其编码人胶原聚糖识别蛋白相关蛋白(本文称为PGRP-K(角质形成细胞),PGRP-W(伤口愈合)和PGRP-C(软骨肉瘤))。 图1A-B, 图2A-C, 3,分别与人肽聚糖识别蛋白(PGRP)以及鼠Tag-7都具有同源性。 还提供了PGRP-K,PGRP-W和PGRP-C多肽。 进一步提供载体,宿主细胞和用于制备其的重组方法。 本发明还涉及PGRP-K,PGRP-W和PGRP-c多肽的活性的抑制和增强以及用于检测PGRP-K,PGRP-W和PGRP-C基因表达的诊断方法。
    • 20. 发明授权
    • Peptidoglycan recognition proteins
    • 肽聚糖识别蛋白
    • US07041802B2
    • 2006-05-09
    • US10180454
    • 2002-06-27
    • Paul E. YoungSteven M. RubenCraig A. RosenHenrik S. Olsen
    • Paul E. YoungSteven M. RubenCraig A. RosenHenrik S. Olsen
    • C07K16/00C12P21/08C12N5/06G01N33/53
    • C07K14/47A61K38/00
    • The present invention relates to three novel peptidoglycan recognition binding proteins expressed by keratinocytes, wound-healing tissues and chondrosarcoma tissue. More specifically, isolated nucleic acid molecules are provided encoding human peptidoglycan recognition protein-related proteins, referred to herein as PGRP-K (Keratinocytes), PGRP-W (Wound-healing), and PGRP-C (Chondrosarcoma) of FIGS. 1A–B, FIGS. 2A–C, and FIG. 3, respectively, each having homology to both human peptidoglycan recognition protein (PGRP) as well as murine Tag-7. PGRP-K, PGRP-W, and PGRP-C polypeptides are also provided. Further provided are vectors, host cells and recombinant methods for producing the same. The invention also relates to both the inhibition and enhancement of activities of PGRP-K, PGRP-W, and PGRP-c polypeptides and diagnostic methods for detecting PGRP-K, PGRP-W, and PGRP-C gene expression.
    • 本发明涉及由角质形成细胞,伤口愈合组织和软骨肉瘤组织表达的三种新的肽聚糖识别结合蛋白。 更具体地,提供分离的核酸分子,其编码人胶原聚糖识别蛋白相关蛋白(本文称为PGRP-K(角质形成细胞),PGRP-W(伤口愈合)和PGRP-C(软骨肉瘤))。 图1A-B, 图2A-C, 3,分别与人肽聚糖识别蛋白(PGRP)以及鼠Tag-7都具有同源性。 还提供了PGRP-K,PGRP-W和PGRP-C多肽。 进一步提供载体,宿主细胞和用于制备其的重组方法。 本发明还涉及PGRP-K,PGRP-W和PGRP-c多肽的活性的抑制和增强以及用于检测PGRP-K,PGRP-W和PGRP-C基因表达的诊断方法。